The global stem cell therapy market is projected to grow at a compound annual growth rate of 36.52 percent between 2017 and 2021, according to an analysis by Wise Guy Reports.
The market is propelled forward by an increase in federal funding for stem cell therapy. Here are five key vendors.
1. Holostem Advanced Therapies
2. JCR Pharmaceuticals
3. Organogenesis
4. Osiris Therapeutics
5. Vericel
More articles on biologics:
Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know